Celyad SA (CYAD) Social Stream
CELYAD ONCOLOGY SA (CYAD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CYAD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 2 | $15 | $15 | $15 | $0.47 | 3091.49% |
| 2021-12-10 | 2 | $13 | $13 | $13 | $0.47 | 2665.96% |
| 2022-01-11 | 2 | $11 | $11 | $11 | $0.47 | 2240.43% |
| NA | 1 | $NA | $NA | $NA | $0.47 | NA% |
The Trend in the Analyst Price Target
Over the past 16 months, CYAD's average price target has gone down $8.34.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
CYAD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
CYAD's average broker recommendation rating improved by 0 over the prior 153 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CELYAD ONCOLOGY SA's number of analysts covering the stock is greater than 26.49% of them.
- To contextualize these metrics, consider that out of all US stocks, CELYAD ONCOLOGY SA's upside potential (average analyst target price relative to current price) is greater than 593.64% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CELYAD ONCOLOGY SA's variance in analysts' estimates is lower than 91.81% of them.
- In the context of Healthcare stocks, CELYAD ONCOLOGY SA's average analyst price target is greater than 136.83% of them.
In the Pharmaceutical Products industry, RDHL, KMDA, and IMMP are the three stocks most similar to CELYAD ONCOLOGY SA regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CYAD a Buy, Hold or Sell? See the POWR Ratings now!